NCT00958165已完成3 期
Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (CFEAS- AC) for the Treatment of Symptomatic Atrial Fibrillation
适应症
干预措施
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- CardioFocus
- 入组人数
- 81
- 试验地点
- 3
- 主要终点
- Chronic Effectiveness in Treating PAF as Demonstrated by no AF Recurrences After the Blanking Period and During the 12-month Follow-up Period.
研究概览
简要总结
The purpose of this study is to determine the safety and effectiveness of the endoscopic ablation system - adaptive contact (EAS-AC) in treated paroxysmal atrial fibrillation (PAF) with pulmonary vein isolation (PVI).
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Symptomatic, Paroxysmal atrial fibrillation (AF)
- •18 to 70 years of age
- •Failure of at least one AAD
排除标准
- •Generally good overall health as determined by multiple criteria
- •Willing to participate in a study
研究组 & 干预措施
EAS-AC
Experimental
PVI with EAS-AC
干预措施: CardioFocus EAS-AC (Device)
结局指标
主要结局
Chronic Effectiveness in Treating PAF as Demonstrated by no AF Recurrences After the Blanking Period and During the 12-month Follow-up Period.
时间窗: 12 months
次要结局
未报告次要终点
研究者
研究点 (3)
Loading locations...
相似试验
已完成
2 期
Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial FibrillationParoxysmal Atrial FibrillationNCT00971204CardioFocus100
已完成
3 期
HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF)Paroxysmal Atrial FibrillationNCT01456000CardioFocus405
已完成
4 期
Post-Market Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (CF-EAS-AC) for the Treatment of Symptomatic Atrial FibrillationAtrial FibrillationNCT01196923CardioFocus20
已完成
2 期
Adenovirus Vascular Endothelial Growth Factor D (AdvVEGF-D) Therapy for Treatment of Refractory Angina PectorisRefractory Angina PectorisCoronary Artery DiseaseGene TransferNCT03039751Kuopio University Hospital63
Unknown
不适用
Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic NeoplasmsPancreatic NeoplasmsPancreatic Neuroendocrine TumorPancreatic Ductal AdenocarcinomaPancreatic AdenocarcinomaPancreatic CancerNCT03435770Singapore General Hospital10